Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

A fixed-dose inhaled corticosteroid/long-acting β(2)-agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and formoterol fumarate (BDP/FF) has been recently approved for use in chronic obstructive pulmonary disease (COPD). Small airway inflammation and remodelling are cardinal feat...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910970/
https://www.ncbi.nlm.nih.gov/pubmed/27309985
http://dx.doi.org/10.1038/npjpcrm.2016.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910970/
https://www.ncbi.nlm.nih.gov/pubmed/27309985
http://dx.doi.org/10.1038/npjpcrm.2016.30

Ejemplares similares